Chromogranin A levels to predict survival in resectable pancreatic neuroendocrine tumors.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e15775
Abstract: e15775Background: To determine whether Chromogranin A (CGA) predicts outcome after Cytoreductive Surgery (CRS) for Pancreatic Neuroendocrine Tumors (PNETs). CGA is used by clinicians to monitor pro... read more here.
Keywords: predict survival; chromogranin levels; pancreatic neuroendocrine; levels predict ... See more keywords